Adamas Pharma Cmn (NASDAQ:ADMS).
Brenner West Capital Advisors, Lp says it increased its investment in Adamas Pharma Cmn by 281,321 shares in the quarter ending 09/30/2017. Its stake was valued at $36,020,000 an increase of $11,181,000 as of the end of the quarter.
Here are a few institutional investors who have updated their positions. As of the end of the quarter Jpmorgan Chase & Co had acquired 135,235 shares growing its position 13,028.4%. The value in dollars increased from $18,000 to $2,839,000 a change of $2,821,000 quarter to quarter. As of quarter end Great Point Partners LLC had sold a total of 1,960,011 shares trimming its stake by 88.4%. The value of the investment in ADMS went from $38,764,000 to $5,427,000 decreasing 86.0% since the last quarter.
As of the end of the quarter Millennium Management LLC had acquired 923,203 shares growing its holdings by 273.6%. The value of the total investment in Adamas Pharma Cmn went from $5,901,000 to $26,686,000 a change of 352.2% for the reporting period.
Equity analyst Noble Financial raised the price target on November 8 changing the price objective from $33.00 to $48.00 and stated a “Buy” rating. Equity analyst Evercore ISI updated guidance on ADMS with an initial rating of “Outperform”.
On October 4 Piper Jaffray Companies kept the stock rating at “Overweight” projecting a price of $30.00. September 29 investment analysts at Noble Financial maintained a stock rating of “Buy” targeting a price of $33.00.
On September 20 Piper Jaffray Companies maintained a company rating of “Overweight” with a current price target of $30.00. September 19 investment analysts at Mizuho held the company rating at “Buy” with a current price target of $48.00.
The company is trading up by 4.42% since yesterday’s close of 26.71. The P/E ratio is N/A and market cap is 635.30M. As of the latest earnings report the EPS was $-3.36 with 22.78M shares currently outstanding.
Traders are a little more bearish on shares of the company lately if you pay attention to the uptick in short interest. The firm recorded a rise in short interest of 10.44% as of October 13, 2017 from the last reporting period. Short interest grew from 6,722,101 to 7,424,033 over that period. The short-interest ratio increased to 9.0 and the short interest percentage is 0.33% as of October 13.